Cargando…
46,XY disorder of sexual development resulting from a novel monoallelic mutation (p.Ser31Phe) in the steroid 5α-reductase type-2 (SRD5A2) gene
Inactivating mutations of the 5α-steroid reductase type-2 (SRD5A2) gene result in a broad spectrum of masculinization defects, ranging from a male phenotype with hypospadias to a female phenotype with Wolffian structures. Molecular studies of the SRD5A2 revealed a new heterozygous gene variant withi...
Autores principales: | Chávez, Bertha, Ramos, Luis, Gómez, Rita, Vilchis, Felipe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113269/ https://www.ncbi.nlm.nih.gov/pubmed/25077171 http://dx.doi.org/10.1002/mgg3.76 |
Ejemplares similares
-
Try235Phe homozygous mutation of the steroid 5-a reductase type 2 (SRD5A2) gene in a Turkish patient
por: Parlak, Mesut, et al.
Publicado: (2014) -
Crystal structure of steroid reductase SRD5A reveals conserved steroid reduction mechanism
por: Han, Yufei, et al.
Publicado: (2021) -
Identification of a novel mutation in the SRD5A2 gene of one patient with 46,XY disorder of sex development
por: Li, Shu-Ping, et al.
Publicado: (2018) -
Mutations in AR or SRD5A2 Genes: Clinical Findings, Endocrine Pitfalls, and Genetic Features of Children with 46,XY DSD
por: Akcan, Neşe, et al.
Publicado: (2022) -
The pathogenic role of the BRCA2 c.7847C>T (p.Ser2616Phe) variant in breast and ovarian cancer predisposition
por: Yamazawa, Kazuki, et al.
Publicado: (2023)